Chemcon Speciality Chemicals reported a strong financial performance for the half-year ended September 30, 2026, with net profit rising to Rs 18.48 crore. Revenue also saw healthy growth, reaching Rs 131.94 crore compared to Rs 107.23 crore in the previous year. The company’s Board of Directors met on October 24, 2026, and decided against recommending a dividend for the period. The financial results received an unmodified review report from statutory auditors.
Chemcon Speciality Chemicals H1 Net Profit Hits Rs 18.48 Crore
Revenue for H1 FY27 reached Rs 131.94 crore, up from Rs 107.23 crore in H1 FY26.
Net profit for the half-year stood at Rs 18.48 crore, compared to Rs 12.13 crore in the prior year.
Reader Takeaway: Strong top-line and bottom-line expansion signals operational growth, though the lack of dividend may disappoint income-focused retail investors.
What just happened
Chemcon Speciality Chemicals released its financial results for the quarter and half-year ended September 30, 2026. The company reported a significant 52% year-on-year increase in net profit for the first half of the fiscal year. The results were reviewed by statutory auditors Shah Mehta & Bakshi, who provided an unmodified report confirming compliance with SEBI regulations.
Why this matters
The steady growth in both revenue and profit underscores the company's ability to navigate the specialty chemicals market effectively. While profitability is on an upward trajectory, the Board of Directors, during their October 24, 2026, meeting, deliberated on a dividend proposal but ultimately decided not to declare one at this time.
Context metrics
For the quarter ended September 30, 2026, the company recorded a net profit of Rs 7.52 crore, improving from Rs 5.75 crore in the same quarter last year. The revenue growth of approximately 23% for the half-year reflects sustained demand for the company's chemical products.
What to track next
Investors should monitor the company's quarterly margin consistency and any future updates regarding capital allocation or dividend policy in upcoming board meetings. The company operates without significant subsidiary or joint venture complications, making its core performance the primary metric for valuation.
